<?xml version="1.0" encoding="UTF-8"?>
<p>In parallel with this greater political attention, several major donor organisations have increased their funding of NID research. Despite the financial crisis, overall global R&amp;D funding for 13 neglected tropical diseases increased by more than 70% between 2007 and 2011, from US$268 million to US$464 million 
 <xref rid="bb0040" ref-type="bibr">[8]</xref>. This has partly been a consequence of increased donations from private charitable organisations such as the Bill and Melinda Gates Foundation, but LMICs, in particular some emerging economies, have also begun to support NID research on a larger scale. More academic and public research organisations have therefore increased their engagement in NID research, while a number of pharmaceutical companies have created dedicated facilities for the development of new interventions against NIDs.
</p>
